Denali Therapeutics DNLI reported primary analysis data from an early to mid-stage study of its pipeline candidate, tividenofusp alfa (DNL310), in 47 patients with Hunter syndrome (MPS II) over a ...

The Better Results Doug Bates Philosophy In an industry traditionally focused on metrics, such as how much you can lift or the number of squats you perform, Doug Bates offers a different ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Long-term data demonstrate that robust reductions and normalization in key biomarkers from baseline were maintained over time with continued ...

As scientists unravel how sleep benefits the body, a study in mice is highlighting the potential pitfalls of using Ambien and other sleeping pills.

Denali Therapeutics (DNLI) announced the primary analysis of the Phase 1/2 study in 47 participants with Hunter syndrome in the 24-week ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients ...

Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery model ...

The first French multirole fighters Mirage 2000-5F have arrived in Ukraine, marking a new step in France's military support ...

"With Ukrainian pilots trained for several months in France on board, they will now participate in defending Ukraine's sky," ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

What has puzzled researchers and philosophers for many centuries is the ‘why’ of sleep, along with the ‘how’. We human animals know from experience that we need to sleep, ...